AlphaFold predicted structure
COLGALT1 · Q8NBJ5

Mean pLDDT
87.9/ 100
Confident
622 residues
Confidence breakdown
- Very high(≥ 90)74%
- Confident(70–90)12%
- Low(50–70)7%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
collagen beta(1-O)galactosyltransferase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Familial cerebral small vessel disease
BIALLELIC, autosomal or pseudoautosomalInherited white matter disorders
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalcerebral small vessel disease
hereditary disease
familial porencephaly
response to COVID-19 vaccine
vascular dementia
Genetic visceral malformation of the liver, biliary tract, pancreas or spleen
neoplasm
hepatocellular carcinoma
Hepatic fibrosis
digestive system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Procollagen galactosyltransferase 1
Beta-galactosyltransferase that transfers beta-galactose to hydroxylysine residues of type I collagen (PubMed:19075007, PubMed:22216269, PubMed:27402836). By acting on collagen glycosylation, facilitates the formation of collagen triple helix (PubMed:27402836). Also involved in the biosynthesis of collagen type IV (PubMed:30412317)
COLGALT1 · Q8NBJ5

Mean pLDDT
87.9/ 100
Confident
622 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0